Miromatrix Medical acquired by United Therapeutics two years after IPO


Miromatrix, which is developing a process to engineer organs for transplantation, went public in 2021.

Previous Silver Spring's United Therapeutics reaches $91M deal to buy Miromatrix Medical
Next Denver company strikes $21 billion health care real estate deal